IL6 and gastric cancer: Together, these results demonstrate that antagonizing miR-BART20-3p upregulates PPARα and concomitantly downregulates IL-6, reinforcing the functional miR-BART20-3p–PPARα–IL-6 axis in EBV-associated gastric cancer.